Outcomes of intradetrusor onabotulinum toxin A injection in patients with Parkinson's disease-Reference-Cited by-同舟云学术

Outcomes of intradetrusor onabotulinum toxin A injection in patients with Parkinson's disease

Published:2018-05-16 Issue:8 Volume:37 Page:2669-2677
ISSN:0733-2467
Container-title:Neurourology and Urodynamics
language:en
Short-container-title:Neurourology and Urodynamics

Author:

Vurture Gregory¹^ORCID,Peyronnet Benoit¹²,Feigin Andrew³,Biagioni Milton C.³,Gilbert Rebecca³,Rosenblum Nirit³,Frucht Steven³,Di Rocco Alessandro³,Nitti Victor W.¹,Brucker Benjamin M.¹

Affiliation:

1. Department of Urology; New York University School of Medicine; New York New York

2. Department of Urology; University of Rennes; Rennes France

3. The Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders; New York University School of Medicine; New York New York

Publisher

Wiley

Subject

Urology,Clinical Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/nau.23717/fullpdf

Reference34 articles.

1. Lower urinary tract dysfunction in patients with parkinsonism and other neurodegenerative disorders;Winge;Handb Clin Neurol,2015

2. Prevalence and treatment of LUTS in patients with Parkinson disease or multiple system atrophy;Ogawa;Nat Rev Urol,2017

3. Parkinson's disease and its effect on the lower urinary tract;Brucker;Urol Clin North Am,2017

4. Guideline of guidelines: urinary incontinence;Syan;BJU Int,2016

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lower urinary tract dysfunction in the central nervous system neurogenic bladder and the real-life treatment outcome of botulinum toxin A;Tzu Chi Medical Journal;2024-05-24

2. Outcomes of sequential third‐line therapies in patients with refractory overactive bladder;International Journal of Urology;2024-05-02

3. Sleep and Overactive Bladder in Parkinson’s Disease;Urologic Clinics of North America;2024-05

4. Real-Life Treatment Outcome of Botulinum Toxin A Injection on Overactive Bladder and Voiding Dysfunction in Patients with Central Nervous System Lesions;Toxins;2024-03-01

5. Botulinum Toxin for the Management of Parkinson’s Disease: A Systematic Review;Cureus;2024-01-31